Stay for the title, leave if you want to be paid market value - Executive Director Bayer Employee Review

4.0
Feb 4, 2023
Recommend
CEO approval
Business Outlook

Pros

Amazing people, good work life balance, amazing benefits, unsurpassed retirement benefits.

Cons

Pharma performance dragged down by Xarelto and Eyelea going off patent, coupled with Monsanto lawsuits depressing the stock, your LTI and STI barely hit the target. Salary is barely median within industry, yet HR takes the stance it's competitive. Oncology pipeline has dried up, new management not able to make a decision on acquisitions to save their life and their entire pipeline commercialization team has been dissolved (their BD&L team is led by a confused lady, at best). They are hanging by a Nubeqa thread that has a peak potential of 4bn, yet Bayer has 100bn of debt on the books. So get promoted and move up, then move on.

Explore other reviews about Bayer

5.0
May 21, 2026
Recommend
CEO approval
Business Outlook

Pros

Good team , good cafeteria

Cons

Bad office , bad weather

3.0
Jun 11, 2026
Recommend
CEO approval
Business Outlook

Pros

Better pay than other companies My team - full of hardworking and knowledgable individuals.

Cons

Leadership/Management - can be micromanaging at times and not a lot of guidance/resources being provided. Projects can change swiftly at Bayer, and most of the times there's no background context given. Work/life balance - asked to be "flexible" with schedule for last-minute requests, then criticized for having life/responsibilities outside of work. Also, these last minute requests reflect poor planning on management. Lack of team morale - seems like it's all work and not a lot of play. Burnout culture and not a lot of incentives to perform better.

See reviews by: Helpful|Rating|Date|All